Berta Moritz
Impact in
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 3
-
- Venous Thromboembolism Diagnosis and Management 3
- Co-authors
- Jan Antonius Hazelzet (1 shared paper)Werner Engl (1 shared paper)Ronald de Groot (1 shared paper)C. Erik Hack (1 shared paper)Ester D. de Kleijn (1 shared paper)Paul G.H. Mulder (1 shared paper)Koen F. M. Joosten (1 shared paper)Ulrich Jaehde (8 shared papers)
- Journals
- Annals of Oncology (2 papers)Clinical Pharmacokinetics (2 papers)European Journal of Cancer (2 papers)CPT Pharmacometrics & Systems Pharmacology (1 paper)Critical Care Medicine (1 paper)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Berta Moritz
17 papers receiving 484 citations
Peers
Comparison fields: 5 of 72
- Hematology 89
- Oncology 177
- Internal Medicine 21
- Epidemiology 121
- Microbiology 22
Countries citing papers authored by Berta Moritz
This map shows the geographic impact of Berta Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Moritz more than expected).
Fields of papers citing papers by Berta Moritz
This network shows the impact of papers produced by Berta Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Moritz. The network helps show where Berta Moritz may publish in the future.
Co-authors
The 25 scholars most cited alongside Berta Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 184 | |
| 2 | 2016 | 75 | |
| 3 | 2016 | 59 | |
| 4 | 2014 | 55 | |
| 5 | 2012 | 51 | |
| 6 | 2017 | 24 | |
| 7 | 1995 | 17 | |
| 8 | 2014 | 8 | |
| 9 | A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment. | 2011 | 6 |
| 10 | 1995 | 5 | |
| 11 | 2002 | 4 | |
| 12 | 2015 | 4 | |
| 13 | 2016 | 4 | |
| 14 | A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment - a study of the CESAR central european society for anticancer drug research - EWIV** | 2011 | 4 |
| 15 | 2014 | 4 | |
| 16 | 2015 | 3 | |
| 17 | 2012 | 1 | |
| 18 | 1996 | 0 |
About Berta Moritz
Berta Moritz is a scholar working on Oncology, Internal Medicine, Pulmonary and Respiratory Medicine, Hematology and Cancer Research, having authored 18 papers that have together received 508 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Cancer Treatment and Pharmacology (3 papers), Renal cell carcinoma treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (2 papers) and Atrial Fibrillation Management and Outcomes (2 papers). The work is most often cited by research in Hematology (89 citations), Oncology (177 citations), Internal Medicine (21 citations), Epidemiology (121 citations) and Microbiology (22 citations). Berta Moritz has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Jan Antonius Hazelzet, Werner Engl, Ronald de Groot, C. Erik Hack, Ester D. de Kleijn, Paul G.H. Mulder, Koen F. M. Joosten, Ulrich Jaehde, Stefanie Kraff and Alwin D. R. Huitema. Their work appears in journals such as Annals of Oncology, Clinical Pharmacokinetics, European Journal of Cancer, CPT Pharmacometrics & Systems Pharmacology and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.